2,3-Dihydro-isoindol-1-one derivatives, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them, for the prevention and treatment of diseases which are mediated by monoamine oxidase B.
2,3-DIHYDRO-ISOINDOL-1-ONES WITH MAO-B INHIBITING ACTIVITY
申请人:F. Hoffmann-La Roche AG
公开号:EP1539694A1
公开(公告)日:2005-06-15
TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES
申请人:Oryzon Genomics SA
公开号:EP2195029A2
公开(公告)日:2010-06-16
MAO-B INHIBITORS USEFUL FOR TREATING OBESITY
申请人:McElroy Francis John
公开号:US20070078172A1
公开(公告)日:2007-04-05
The invention provides a method of treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance) in a mammal by administering to the mammal a therapeutically effective amount of an irreversible MAO-B inhibitor.